PervasID scoops the Business Innovation and Best Enterprising Business Awards at SME Cambridgeshire Business Award ceremony 2019

Double nomination secures PervasID a place in the National SME Business Awards Ceremony finals

Cambridge 8th July 2019.  PervasID, developers of next-generation radio frequency identification (RFID)-based tag reading solutions with 99% plus accuracy, scooped two major awards at the SME Cambridgeshire Business Awards Ceremony, which took place at the Imperial War Museum in Duxford on the 4th July. More than 100 finalists attended the ceremony.

The prestigious event, now in its third year, helps raise the profile of industrious, hardworking and enterprising SMEs across the region. A total of 20 awards were presented to businesses and individuals that have demonstrated success and made impressive contributions within their respective industry sectors. PervasID secured the Regus Best Enterprising Business and the Calver Wealth Management Business Innovation trophies. A judge from the latter category stated; “Great results from taking risks in a highly competitive technical world. Sustainable investment to innovate the business further.”

 

 As a winner in both core categories, PervasID automatically qualifies to participate in the National SME Business Awards Ceremony Finals, being held at Wembley Stadium in December.

 

“We are absolutely delighted with this double nomination,” says Dr Sabesan Sithamparanathan, Co-Founder and CEO of PervasID. “To be given this kind of recognition is a real motivator for our talented R&D team who are constantly refining our core technology to ensure we remain at the forefront of accurate RFID tag detection.”

 

Born out of the Department of Engineering at the University of Cambridge, PervasID’s RAIN RFID tracking products are streamlining operations and automating inventory and asset management processes across a wide range of industries including industrial manufacturing, warehousing & logistics, aviation, retail and healthcare.

In 2018, PervasID secured £1.6million in series A funding from Parkwalk, Cambridge Innovation Capital and Martlet to further accelerate development of its ground breaking technology and to expand its commercial presence Europe, North America and Asia.